A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 176 participants.
Also called NCT02492763
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 176 participants
- Sponsor
- Registry
-
NCT02492763
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Terminated
Technical summary
Registry record NCT02492763. Randomized; double masking; primary purpose treatment. Start 2015-07-27 (actual); primary completion 2017-04-18 (actual). Results posted on 2018-03-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
- Condition
- Type II Diabetes Mellitus
- Intervention (Drug)
- MK-8521
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Liraglutide
- Intervention (Drug)
- Metformin
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct02492763- Content hash
02f9eedd0a71f4df413966510a3565dc1fee5a7316324cf12c859f525f08a685